Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
420 participants
INTERVENTIONAL
2003-01-31
2004-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extended-Release Bupropion Hydrochloride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must engage in sexual activity that leads to orgasm at least once every two weeks.
* Subject must have normal orgasmic function and be willing to discuss with investigator.
Exclusion Criteria
* Has previously failed to respond to two adequate trials of antidepressants in past 2 years.
* Subject has other unstable medical disorders.
* Subject has a positive urine test for illicit drug use at screening.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GSK
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials, MD
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Berkeley, California, United States
GSK Investigational Site
Beverly Hills, California, United States
GSK Investigational Site
La Mesa, California, United States
GSK Investigational Site
Oceanside, California, United States
GSK Investigational Site
Coral Springs, Florida, United States
GSK Investigational Site
Jacksonville, Florida, United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Terre Haute, Indiana, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Rockville, Maryland, United States
GSK Investigational Site
Minneapolis, Minnesota, United States
GSK Investigational Site
New York, New York, United States
GSK Investigational Site
Cleveland, Ohio, United States
GSK Investigational Site
Toledo, Ohio, United States
GSK Investigational Site
Tulsa, Oklahoma, United States
GSK Investigational Site
Eugene, Oregon, United States
GSK Investigational Site
Portland, Oregon, United States
GSK Investigational Site
Lincoln, Rhode Island, United States
GSK Investigational Site
Charleston, South Carolina, United States
GSK Investigational Site
Bellaire, Texas, United States
GSK Investigational Site
Charlottesville, Virginia, United States
GSK Investigational Site
Richmond, Virginia, United States
GSK Investigational Site
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK130926
Identifier Type: -
Identifier Source: org_study_id